Keywords: neurocrine, cuts, loss, despite, sales, drop, biosciences

Neurocrine cuts loss despite 59% sales drop

Article | 08 May 2009

Print This

Neurocrine Biosciences cut its loss by 7% year-on-year for the first quarter of 2009, despite lower revenue from a royalty payment reduction ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in